NeoPharm CO., LTD. (KOSDAQ: 092730)
South Korea
· Delayed Price · Currency is KRW 13,070
+60 (0.46%)
Nov 15, 2024, 9:00 AM KST
NeoPharm CO., LTD. Revenue
NeoPharm CO., LTD. had revenue of 30.62B KRW in the quarter ending June 30, 2024, with 24.99% growth. This brings the company's revenue in the last twelve months to 107.86B, up 20.79% year-over-year. In the year 2023, NeoPharm CO., LTD. had annual revenue of 97.10B with 14.20% growth.
Revenue (ttm)
107.86B
Revenue Growth
+20.79%
P/S Ratio
1.87
Revenue / Employee
627.08M
Employees
172
Market Cap
201.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 97.10B | 12.07B | 14.20% |
| Dec 31, 2022 | 85.03B | -2.90B | -3.30% |
| Dec 31, 2021 | 87.93B | 6.31B | 7.72% |
| Dec 31, 2020 | 81.63B | -1.61B | -1.94% |
| Dec 31, 2019 | 83.24B | 16.97B | 25.60% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition